Context Therapeutics | DEFA14A: Others
Apr 26 16:33 ET
Context Therapeutics | ARS: Annual Report to Security Holders
Apr 26 16:25 ET
Context Therapeutics | DEF 14A: Definitive information statements
Apr 26 16:19 ET
Context Therapeutics | 8-K: Current report
Apr 1 07:36 ET
Context Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Minai-Azary Jennifer Lynn
Mar 22 08:07 ET
Context Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Levit Alex C.
Mar 22 08:07 ET
Context Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lehr Martin A.
Mar 22 08:02 ET
Context Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Mar 21 08:31 ET
Context Therapeutics | 10-K: Annual report
Mar 21 07:40 ET
Context Therapeutics | 8-K: Current report
Mar 21 07:36 ET
Context Therapeutics | 8-K: Current report
Mar 6 07:33 ET
Context Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Affinity Healthcare Fund, LP (EIN(2.06%),Affinity Asset Advisors, LLC (EIN(2.06%)
Feb 13 16:51 ET
Context Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Martin Lehr(8.8%),Martin Lehr 2000 Trust(5.1%), etc.
Feb 7 16:27 ET
Context Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Opaleye Management Inc.(5.14%)
Jan 5 00:00 ET
Context Therapeutics: Q3 2023 Earnings Report
Nov 9, 2023 16:04 ET
Context Therapeutics | 8-K: Current report
Oct 31, 2023 09:04 ET
Context Therapeutics | 10-Q: Q2 2023 Earnings Report
Aug 9, 2023 16:04 ET
Context Therapeutics | 8-K: Current report
Aug 7, 2023 08:11 ET
Context Therapeutics | 8-K: Current report
Jun 20, 2023 08:35 ET
Context Therapeutics | 8-K: Current report
Jun 2, 2023 16:05 ET
No Data
No Data